Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...
In 1993, the first effective enzyme replacement therapy (ERT) for a genetic disease, Ceredase (Genzyme Corporation, Cambridge, MA), was approved for use in patients with Gaucher disease. Over the next ...
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas (Mar. 3, 2021) – Brooke Army Medical Center opened a new Infusion Clinic to help high risk COVID-positive patients whose symptoms are mild to moderate.